Dear Dammy,
Irritable Bowel Syndrome (IBS) is a common, chronic gastrointestinal condition now recognised as a disorder of gut–brain interaction. It is frequently encountered in community pharmacy, where many patients continue to experience symptoms despite prior treatment or self-management. IBS significantly affects quality of life and productivity, highlighting ongoing unmet needs in symptom control and patient support.
We invite you to join C+D and FyboCalm on Tuesday, 19 May, 2026 at 2pm GMT for a an insightful session designed to support pharmacy professionals in advancing their understanding and management of IBS in practice.
In this session, we will explore the evolving understanding of IBS pathophysiology, including the role of gut–brain interaction and intestinal barrier dysfunction. You’ll gain practical insights into the prevalence and burden of IBS in the UK, along with a review of current management approaches, covering lifestyle interventions, OTC options, and prescribed therapies.
What you will learn:
- How to recognise IBS as a disorder of gut–brain interaction and its relevance to symptom presentation
- How to describe the prevalence and impact of IBS in the UK and identify common unmet needs in pharmacy
- Current IBS management options
- Mechanism of action of xyloglucan in supporting intestinal barrier function
- How to apply clinical evidence to inform patient counselling, product recommendation, and referral decisions
MEET THE SPEAKERS
Nana Ofori-Atta
Clinical and Custom Content Editor, C+D
Nana Ofori-Atta, a seasoned pharmacist, brings a wealth of expertise as the Clinical and Custom Content Editor at C+D. Since joining in 2022, Nana has played a pivotal role in crafting insightful clinical content and developing our learning content. With a keen grasp of pharmaceutical practices, he ensures content meets the highest standards of accuracy and relevance. Nana’s dedication to empowering pharmacists with up-to-date information makes him an invaluable asset to the C+D team.
Dr Elsa Lopez Pintor
Professor of Pharmacy and Pharmaceutical Technology, University Miguel Hernandez of Elche
Dr Elsa Pintor is an assistant professor at the University Miguel Hernandez of Elche (UMH), Alicante, in the southeast of Spain, member of the researcher group in Global Health, UMH, and researcher in the Biomedical Research Networking Centre for Epidemiology and Public Health, CIBERESP, Madrid, Spain (CIBERESP is the public research consortium set up by the Instituto de Salud Carlos III (ISCIII). She has authored over 70 national and international journal papers and conferences, posters and book chapters, and received several research awards. She has taught at the pharmacy degree of UMH as well as PhD studies and master´s degrees for community pharmacists and other healthcare professionals. Responsible for the design and direction of a master’s course in Pharmaceutical Care and Management of Community Pharmacy, UMH.
- FyboCalm is a medical device. Always read the instructions
- Only FyboCalm Constipation and FyboCalm Diarrhoea Relief are indicated in IBS
- Approval code RT-M-rr0e2k – March 2026
Don’t want to receive these emails? No problem, simply click on the Unsubscribe link below.
By accessing this content, you are permitting CD Partnered Content or a third party to contact you regarding the content (by phone or email).
© 2026 Marketing Masters Hub. All rights reserved.